Clinical Trial Update: Study to Assess Safety & Immunogenicity of GSK Biologicals' Boostrix (dTpa) Vaccine vs. Chinese DT Vaccine [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing GSK Boostrix (dTpa) with a Chinese diphtheria-tetanus vaccine to assess safety and immunogenicity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Pertussis
• Tetanus

Drugs mentioned

• Boostrix (Diphtheria, Tetanus, and Acellular Pertussis Vaccine)
• DT vaccine (diphtheria-tetanus vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diphtheria, Acellular Pertussis | Phase 3 | Status: COMPLETED